News
Comment: Why early lymphedema detection matters for breast cancer survivors

By Steven Chen, chief medical Officer at medtech firm ImpediMed.
As cancer survival rates continue to climb, healthcare providers must address a critical yet often overlooked long term risk for breast cancer patients and survivors: lymphedema. This condition, characterised by the buildup of protein-rich lymph fluid in tissues, can significantly impact survivors’ quality of life if left undetected and untreated.
This month, as we observe Lymphedema Awareness Month, it’s crucial to highlight the importance of managing this potential side effect of breast cancer care.

Dr Steven Chen, chief medical Officer, ImpediMe
Lymphedema extends far beyond simple swelling. When normal lymphatic drainage is disrupted, it leads to stagnant lymphatic flow and an impaired immune response, potentially resulting in serious complications like cellulitis, a dangerous bacterial skin infection.
The condition also carries a substantial financial burden, with management costs ranging from US$14,877 to US$23,167 over just two years. These figures, coupled with the physical and emotional toll on patients, underscore the urgent need for proactive measures in breast cancer care plans.
Transforming Detection and Prevention
Historically, healthcare providers often waited until lymphedema symptoms became visible and chronic before intervening – often too late for optimal treatment.
Today, technological advances have revolutionised our approach to detection. Bioimpedance Spectroscopy (BIS), recognised in national and international guidelines, can detect lymphedema in under 60 seconds, long before symptoms appear.
BIS was also recently added to the National Accreditation Program for Breast Centers (NAPBC) standards as an evidence-based guideline, requiring accredited programs to adopt proactive, guideline-driven survivorship care—further advancing early detection and prevention.
BIS works by sending a small electrical current through the body, measuring the resistance and reactance to this current. This non-invasive approach enables precise measurement of extracellular fluid and total body water, helping determine intracellular fluid, fat mass, and fat-free mass.
The technology’s sensitivity to small fluid changes allows for earlier detection compared to traditional tape measurements, making it an invaluable tool in detecting lymphedema early enough to decrease the risk of chronic lymphedema.
A Comprehensive Approach to Care
The key to managing lymphedema lies in implementing a robust surveillance program that begins before cancer treatment starts. It is recommended that patients establish baseline measurements using BIS technology and maintain regular monitoring throughout and following the completion of cancer treatment for at least three years.
This proactive approach allows for immediate intervention when subclinical changes are detected, often preventing progression to chronic lymphedema.
Physical wellness forms the foundation of effective lymphedema management. Patients can benefit from customised exercise programs that maintain limb mobility and function, while proper skin care prevents infections that could compromise the lymphatic system.
Regular hydration and stress management could also play crucial roles in maintaining lymphatic health. When indicated, compression garments provide essential support in managing symptoms and preventing progression.
Beyond Physical Care
Effective lymphedema management must consider the patient’s entire life context. Healthcare providers should focus on integrating care strategies into patients’ daily routines, considering their work environments, family responsibilities, and personal goals.
This comprehensive approach includes providing access to support resources, educational materials about lifestyle modifications, and tools for self-monitoring and management.
Digital platforms have emerged as valuable resources, offering educational content, exercise programs, and virtual support communities. These tools empower patients to actively participate in their care while maintaining connections with healthcare providers and fellow survivors. The integration of technology into care plans helps ensure consistent monitoring and early intervention when needed.
The Future of Lymphedema Care
As breast cancer treatment continues to improve, our focus must expand beyond survival to encompass the quality of life during and after treatment. The implementation of routine BIS screening represents a step forward in protecting patients from the devastating effects of chronic lymphedema.
Early detection is the key to early intervention, which is the best chance to prevent chronic problems that may require lifelong intensive treatment.
Physicians and other healthcare providers should initiate conversations about lymphedema risk early in the treatment process, making it a routine part of the comprehensive, holistic care of cancer patients.
This early education helps patients understand their risks, encourages them to ask questions about their individual risk factors and early warning signs, reduces unnecessary fear, and empowers them to participate actively in prevention strategies.
The management of lymphedema requires a delicate balance of physical care, emotional support, and lifestyle adaptation. By considering the whole person – their physical needs, emotional well-being, and life circumstances – we can develop more effective, personalized care plans that support long-term health and wellness.
This Lymphedema Awareness Month serves as a reminder that early detection and intervention are crucial in preventing chronic lymphedema. With modern technology and comprehensive care approaches, we have the tools to address this silent threat effectively. By implementing these resources consistently and proactively, we can help ensure that breast cancer survivors not only survive but thrive in their cancer-free lives.
Steven Chen, MD, MBA, serves as the Chief Medical Officer of medical technology company ImpediMed. Previously, Dr. Chen was the chief medical officer for Avelas Biosciences. He has also served as the chief of breast surgery at UC Davis Medical Center, followed by a position as an associate professor of surgery and as the associate programme director of the surgical oncology training programme at City of Hope National Medical Center in Duarte, California. Dr. Chen is a past president of the American Society of Breast Surgeons and serves on committees for a number of professional societies including the American Medical Association, the Society of Surgical Oncology, and the American College of Surgeons. He is also a practicing surgeon in San Diego, California, and the Director of Surgical Oncology at OasisMD.
Menopause
Hormone therapy users report healthier lifestyles

Menopausal women using hormone therapy reported healthier diet, exercise and sleep habits than non-users in a study of more than 10,000 women.
The menopause transition is associated with a higher risk of chronic health conditions and symptoms including hot flushes and problems affecting the urinary and genital systems.
Hormone therapy is often used to manage these symptoms, but it remains unclear whether it affects health outcomes directly or indirectly through changes in health behaviours.
Previous research has produced mixed results, with some studies suggesting that postmenopausal women pay greater attention to maintaining a healthy lifestyle.
The cross-sectional analysis examined whether menopause status and hormone therapy use were linked to diet, physical activity and sleep duration.
A cross-sectional study assesses participants at one point in time. It can identify associations but cannot establish whether one factor directly caused another.
Diet, exercise and sleep are described as modifiable health behaviours because people may be able to change them to improve their health.
The researchers found that postmenopausal women who had never used hormone therapy reported eating less fruit and vegetables.
Women who had never used the treatment were also 19 per cent less likely to meet guidelines for muscle-strengthening activity.
Sleep duration was shorter among postmenopausal women who had never used hormone therapy.
Compared with premenopausal and perimenopausal women, the likelihood of meeting sleep guidelines was 14 per cent lower among never-users, 26 per cent lower among current users and 24 per cent lower among past users.
Perimenopause is the transitional period before menopause, when hormone levels and menstrual periods can change.
Researchers said these findings may be linked to higher levels of follicle-stimulating hormone among postmenopausal women who do not use hormone therapy.
They may also relate to lower levels of oestradiol, a form of oestrogen, which have previously been associated with poorer sleep.
Hot flushes and urogenital symptoms can also disrupt sleep, although hormone therapy may ease these symptoms.
Dr Stephanie Faubion, medical director for The Menopause Society, said: “This large observational study underscores that women who use hormone therapy tend to adopt overall healthier lifestyles.
“Although this association may partly reflect better symptom control enabling healthier behaviours, healthy-user bias is likely a significant contributor.
“Women who choose to use hormone therapy are often more proactive in their healthcare and may systematically differ from nonusers in socioeconomic resources, access to care, and health literacy.
“This largely explains why early observational studies of hormone therapy suggested cardiovascular benefits that were not confirmed in subsequent randomised, controlled trials.”
Ageing
Strength training may lower heart disease risk in women, study suggests

Women who do strength training may have a lower risk of major cardiovascular disease, particularly alongside aerobic activity, a study suggests.
Cardiovascular disease is the leading cause of death worldwide. Aerobic activities such as brisk walking, jogging, cycling and swimming are already established ways to help reduce the risk.
Strength or resistance training, also known as RT, is less established as a prevention strategy. It makes muscles work against a force and can involve body weight, free weights, resistance bands or machines.
Current US guidelines recommend at least two days of strength training and 150 minutes of moderate-to-vigorous aerobic activity each week.
They also recommend limiting sedentary behaviour, including prolonged television viewing, which is considered an independent risk factor for cardiovascular disease.
Dr Tianyue Zhang, lead study author and scientist in the department of nutrition at the Harvard T.H. Chan School of Public Health, said: “Despite its established health benefits, RT is often overlooked as a prevention strategy for CVD, and its impact on CVD risk, especially in middle-aged and older women, remains understudied.
“A key question is, how much does it add beyond aerobic activity alone?”
Researchers analysed data from 117,025 women participating in the Nurses’ Health Study and Nurses’ Health Study II.
The two groups had average starting ages of 66.8 and 48.1 years respectively.
The women reported their resistance training every four years, with exercises involving the arms and legs recorded separately.
Time spent watching television was used as the main measure of sedentary behaviour.
The researchers examined exercise and television-viewing habits alongside the incidence of major cardiovascular disease.
Major cardiovascular events included fatal or non-fatal heart attacks, strokes, coronary artery bypass surgery and percutaneous coronary intervention.
Coronary artery bypass surgery redirects blood around narrowed or blocked heart arteries. Percutaneous coronary intervention uses a small balloon, often followed by a stent, to open a narrowed artery.
Higher levels of strength training were associated with a lower risk of major cardiovascular disease, particularly heart attacks.
No statistically significant link with stroke was found when resistance exercise was considered separately.
Women completing at least two hours of strength training a week had a 20 per cent lower risk of major cardiovascular disease and a 44 per cent lower risk of heart attack than those doing none.
Each additional hour a week was associated with a five per cent lower risk of major cardiovascular disease and a 14 per cent lower risk of heart attack.
The associations weakened somewhat after researchers accounted for body mass index and conditions including diabetes, high blood pressure and high cholesterol, but remained clear.
Body mass index, or BMI, compares weight with height and is commonly used to assess whether someone is within a healthy weight range.
Strength training was also linked to additional benefits among women who did aerobic activity.
Women completing at least two hours of strength training and 150 minutes of aerobic activity each week had a 45 per cent lower risk of heart attack than those reporting no physical activity.
Women who met recommendations for strength training, aerobic activity and reduced television viewing had the lowest risks of major cardiovascular disease, heart attack and stroke compared with those who met some or none of the recommendations.
Zhang said: “These findings suggest that, within an already active population, RT is associated with additional reductions in CVD risk above and beyond overall aerobic activity.
“Alongside aerobic activity and reductions in sedentary behaviour, RT may be an important component of public health strategies for cardiovascular prevention in women.”
The study relied on participants reporting their own resistance training, meaning the data may not always have been precise.
Researchers also noted the possible influence of unmeasured factors and the limited diversity of participants.
They were unable to fully separate the effects of the type of resistance training performed from the overall amount completed.
Dr Harlan M. Krumholz, professor at Yale School of Medicine, said: “We have long encouraged resistance training, and this study provides strong evidence to reinforce that message.
“It should be included in a well-rounded health routine to support function and longevity.”
Pregnancy
Women with pre-eclampsia at increased risk of chronic kidney disease, study finds

Women who develop pre-eclampsia face a higher risk of chronic kidney disease and high blood pressure later in life, new research suggests.
The amount of protein found in the urine during pregnancy may help identify those at greatest risk of developing long-term health problems.
Pre-eclampsia usually involves high blood pressure and increased protein in the urine. Some women also experience severe headaches and changes to their vision.
The condition cannot be treated during pregnancy and, in some cases, labour must be induced early to protect both the woman and baby.
The study found that the condition may be linked to longer-term health problems.
Anne Høy Seemann Vestergaard, a medical doctor and PhD at the department of clinical medicine at Aarhus University, said: “What we can see is a clear association between pre-eclampsia and the development of high blood pressure, chronic kidney disease and cardiovascular disease later in life.”
The researchers found that the amount of protein passed in the urine during pregnancy was linked to the risk of developing chronic conditions after giving birth.
Protein in the urine can indicate that the kidneys are not filtering blood normally.
Vestergaard said: “The most surprising finding was how clearly the amount of protein in the urine during pre-eclampsia was linked to the risk of later high blood pressure and chronic kidney disease. Women with moderate to severe protein excretion had a higher risk of both conditions compared with women with low or no protein excretion.”
Among women with pre-eclampsia and moderate to severe levels of protein in the urine, around one in 20 developed chronic kidney disease within 10 years and around one in six developed high blood pressure.
Most women in the study did not develop long-term complications, but the researchers said the increased risk should still be taken seriously because the potential effects can be severe.
Vestergaard said: “At first glance, this may sound like a low number, but it represents a markedly increased risk when the groups are compared. In the group with pre-eclampsia and high levels of protein in the urine, around 1 in 20 women developed chronic kidney disease within ten years, including early stages of the disease, compared with around 1 in 100 in the group with lower or no protein excretion.”
She added: “That is a considerable number in light of the fact that chronic kidney disease is a potentially serious condition that can progress to kidney failure if isn’t diagnosed early.”
The findings suggest women who experience pre-eclampsia may benefit from more systematic monitoring after pregnancy.
Vestergaard said: “Our study suggests that these women may benefit from monitoring of blood pressure and kidney function after pregnancy.”
Menopause4 weeks agoPerimenopause misinformation ‘putting women at risk’
Entrepreneur4 weeks agoWomen’s Health Innovation Summit opens submissions for 2026 Innovation Showcase
Insight2 weeks agoBritish women among angriest in Europe, health survey reveals
News3 weeks agoWomen still being failed when they reach menopause, experts say
Menopause3 weeks agoSweden eyes domestic production of oestrogen patches amid menopause treatment shortage
News3 weeks agoThree menopause innovators shortlisted for Femtech World Award
News1 week agoFemtech World Awards 2026: Winners revealed
Hormonal health2 weeks agoApple Health adds menopause and perimenopause tracking














